Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers ...

BRIDGEWATER, N.J. - Insmed Incorporated (NASDAQ:INSM), a biopharmaceutical company with a market capitalization of $14.57 ...

Cystic fibrosis is a genetic disorder that changes a vital protein in the body, causing a buildup of thick and sticky mucus, ...

Researchers have been trying for decades to stop the cells that damage the lung in people with pulmonary fibrosis. Now a team ...

Trusted source of information on Respiratory Disorders that includes articles, news, videos, animations, quizzes, calculators and drugs.

Vertex Pharmaceuticals (NASDAQ: VRTX) has long been known as the company to turn to for life-saving cystic fibrosis (CF) ...

Interactive panel on day 1 of SCOPE Summit 2025 highlighted the need for inclusive narratives, social listening to understand ...

Albany Medical Center’s adult Cystic Fibrosis Care Center has been treating patients aged 18 and older living with cystic fibrosis (CF).

The U.S. Food and Drug Administration (FDA) approved suzetrigine under the brand name Journavx on Jan. 30, 2025. Journavx is a first-in-class non-opioid painkiller that acts on sodium channels in the ...

The 25th annual Great Strides Walk and 23rd annual 65 Roses 5k at Great Strides, which raises funds and awareness for the Cystic Fibrosis Foundation, will be held at Lee University on Saturday, March ...

On Thursday, Ella’s Niskayuna/Schenectady team faced off against Ava’s Shaker squad in a dual meet, with the Blue Bison ...

Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.